Ryan Marshall, DO
Plastic and Reconstructive Surgery · Asheville, NCNPI 1982855334
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 53 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 17 manufacturers reported payments, led by Mentor Worldwide LLC at 46.7% of the total. Reporting peaked in 2023 at $371 and has fallen 66.5% since, to $125 in 2025. That places this record below the midpoint for plastic and reconstructive surgery clinicians in NC, where the typical reported total is $2,773.
Across 53 payments — averaging $25.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Mentor Worldwide LLC$619
- AbbVie$168
- Organogenesis Inc.$106
- Smith+Nephew$69
- Galderma Laboratories, L.p.$53
- KCI USA, Inc.$49
- plus $262 from 11 others
What the payments were for
- Food & beverage$1,326100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Mentor Worldwide LLC | 19 | $619 |
| AbbVie(2 entities) | 8 | $168 |
| Organogenesis Inc. | 4 | $106 |
| Smith+Nephew | 4 | $69 |
| Galderma Laboratories, L.p. | 3 | $53 |
| KCI USA, Inc. | 3 | $49 |
| Revance Therapeutics, Inc. | 2 | $41 |
| Medtronic | 1 | $34 |
| Acera Surgical, Inc. | 1 | $29 |
| Bioventus LLC | 1 | $27 |
| Convatec Inc. | 1 | $25 |
| Davol Inc. | 1 | $23 |
| Pacira Pharmaceuticals Incorporated | 1 | $20 |
| Aroa Biosurgery Incorporated | 1 | $18 |
| Stryker | 1 | $18 |
| Kerecis Limited | 1 | $17 |
| Olympus America Inc. | 1 | $11 |
How this compares
$1,326 in reported general payments places this provider in the 35th percentile of 55 plastic and reconstructive surgery providers in North Carolina.
See all plastic and reconstructive surgery providers in North Carolina →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cephalexin | 42 | $389 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 23 | $109 |
| Ondansetron OdtOndansetron | 25 | $89 |
| Montelukast Sodium | 12 | $66 |
| Oxycodone Hcl | 12 | $45 |
Paid to pharmacies, not to this prescriber.
Other plastic and reconstructive surgery in Asheville
- Jeffrey MarcusDurham$3.3M
- Anuja AntonyCary$326K
- Peter ArnoldGreensboro$206K
- Joseph HunstadCharlotte$144K
- Charles HultmanRaleigh$70K
- Charles KaysWilmington$69K
- Brian CoanCary$41K
- Benjamin WoodRaleigh$23K
- Mark MorganWilmington$23K
- Michael ZennRaleigh$21K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.